GLIPIZIDE

Course overview

GLIPIZIDE IS A SECOND-GENERATION SULFONYLUREA THAT IS FDA-APPROVED FOR THE TREATMENT OF ADULTS WITH DIABETES MELLITUS TYPE 2. IT IS ADMINISTERED AS AN ADJUNCT TO DIET AND EXERCISE. IT CAN BE COMBINED WITH METFORMIN TO REACH GOAL HBA1C IN PATIENTS WITH NOT ADEQUATE METABOLIC CONTROL IN 3 MONTHS, DESPITE COMPLIANCE WITH DIET, EXERCISE, AND MEDICATION. THIS ACTIVITY WILL HIGHLIGHT THE INDICATIONS, MECHANISM OF ACTION, CONTRAINDICATIONS, ADVERSE EVENT PROFILE, AND POTENTIAL TOXICITY OF GLIPIZIDE PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT CARE OF PATIENTS WITH DIABETES USING GLIPIZIDE.